Investor Relations
News and Event Alert Subscription

You may automatically receive Altus Pharmaceuticals Inc. financial information by email. Please enter your news alert preferences below. Click "Continue" to enter your contact information on the next page.

Already signed up? Click here.
Press Releases
SEC Filings
  
  
  
Webcasts and Events
in advance of any event.
Stock Information
Send me a stock update at the end of the trading day.
Send me a stock update at the end of the week.
Alert me when the stock crosses the following price thresholds:
Current Stock Price is $0.090
    
Alert me when the stock changes more than % in one day.



UNSUBSCRIBE me from all Altus Pharmaceuticals Inc.
investor relations email alerts
.

Our email alerts are in compliance with United States anti-spam regulations. All our Investor Relations alerts provide automated opt-out methods as well as complete contact information.

© 2009 Altus Pharmaceuticals Inc. All Rights Reserved | Terms and Conditions | Privacy Policy | Contact Us

 

This website contains certain “forward-looking” statements. These statements are based on the current estimates and assumptions of Altus Pharmaceuticals Inc. (“Altus” or “the Company”) as of the date of this presentation and are subject to uncertainties and changes in circumstances. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Actual results may vary materially from the expectations contained herein. When used herein, the words “may”, “will”, “should”, “could”, “would”, “plan”, “anticipate”, “believe”, “estimate”, “intend”, “project”, “potential” and “expect” and similar expressions are intended to identify such forward-looking statements. Such forward-looking statements are subject to risks, uncertainties, assumptions and other factors that may cause the actual results of Altus to be materially different from those reflected in such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, those set forth under the headings “Special Note Regarding Forward-Looking Statements”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company's most recent annual or quarterly filing with the Securities and Exchange Commission , as well as those set forth in the Company's other filings with the Securities and Exchange Commission. Except to the extent required by applicable securities laws, Altus is not under any obligation to (and expressly disclaims any such obligation to) update its forward-looking statements, whether as a result of new information, future events, or otherwise. All statements or materials contained on a page of this website are made only as of the date of revision set forth on that page.